CPHI vs KEY
China Pharma Holdings Inc (CPHI) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
CPHI currently screens at market cap $29.0M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the CPHI and KEY stock pages for the full models.
Not investment advice.